Lirequinil

DB19751ExperimentalSmall molecule

Lirequinil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Lirequinil is a benzodiazepine receptor antagonist/agonist. Lirequinil has a monoisotopic molecular weight...

Formula / weight: C₂₆H₂₅ClN₂O₃ · 448.95 g/mol (avg)
Code names: RO-41-3696

Resolves to

Compound

UNII2VUW1087ADCAS143943-73-1ChEMBLCHEMBL2105118ChEBI751225PubChem3045375

Structure

InChIKeyCBSWRAUYCIIUEI-FQEVSTJZSA-NSMILESCCO[C@H]1CCN(C1)C(=O)C1=C2N(CCC3=C2C=C(Cl)C=C3)C(=O)C(=C1)C1=CC=CC=C1

Targets

P30536TSPO

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Lirequinil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account